SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ultragenyx Pharmaceuticals Announces In-Licensing of Clinical-Stage Product Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorders